Table 2.
Demographic, comorbidity, prescription drug use characteristics of people who died of overdose during follow-up, by substance use type.
| Stimulant use only N(%) | Opioid use only N(%) | Both N(%) | Total N(%) | P value | |
|---|---|---|---|---|---|
| 87 (32·0) | 74 (27·2) | 111 (40·8) | 272(100·0) | ||
| Demographics | |||||
| Sex | |||||
| Female | 22(25·3) | 21(28·4) | 32(28·8) | 75(27·6) | 0·340 |
| Male | 65(74·7) | 53(71·6) | 79(71·2) | 197(72·4) | |
| Age | |||||
| < 30 | 21(24·1) | 24(32·4) | 25(22·5) | 70(25·7) | 0·170 |
| 30-39 | 14(16·1) | 13(17·6) | 29(26·1) | 56(20·6) | |
| 40-49 | 28(32·2) | 13(17·6) | 30(27·0) | 71(26·1) | |
| 50+ | 24(27·6) | 24(32·4) | 27(24·3) | 75(27·6) | |
| Health Authority Region | |||||
| Fraser | 26(30·0) | 25(33·8) | 21(18·9) | 72(26·5) | 0·007 |
| Interior | 17(19·5) | 13(17·6) | 18(16·2) | 48(17·6) | |
| Northern | 5(5·6) | – | 5(4·5) | 14(5·1) | |
| Vancouver Coastal | 25(28·7) | 16(21·6) | 56(50·5) | 97(35·7) | |
| Vancouver Island | 14(16·1) | 16(21·6) | 11(9·9) | 41(15·1) | |
| Comorbidities | |||||
| Elixhauser index | |||||
| 0 | 19(21·8) | 34(45·9) | 28(25·2) | 81(29·8) | 0·013 |
| 1 | 21(24·1) | 15(20·3) | 20(18·0) | 56(20·6) | |
| 2 | 19(21·8) | 7(9·5) | 22(19·8) | 48(17·6) | |
| 3+ | 28(32·3) | 18(24·3) | 41(36·9) | 87(32·0) | |
| Prescribed medications (Prior 30 days at baseline) | |||||
| Benzodiazepines | 15(17·2) | 15(20·3) | 19(17.1) | 49(18·0) | 0·839 |
| Z drugs | 8(9·2) | 5(6·8) | 12(10.8) | 25(9·2) | 0·646 |
| Sedatives | 48(55·2) | 52(70·3) | 71(64.0) | 171(62·9) | 0·135 |
| Opioid for pain | 18(20·7) | 16(21·6) | 24(21.6) | 58(21·3) | 0·985 |